Amazon has launched a new Bio Discovery Platform designed to simplify and speed up AI-driven drug research. The cloud-based platform provides researchers and pharmaceutical companies with powerful tools, pre-built models, and massive datasets to streamline the entire drug discovery process from target identification to candidate optimisation.
Glimpse:
The platform integrates Amazon Web Services (AWS) infrastructure with specialised AI and machine learning capabilities tailored for life sciences. It enables faster analysis of biological data, more accurate predictive modelling, and collaborative research workflows, helping reduce the time and cost traditionally associated with bringing new drugs to market.
Amazon has officially entered the AI-powered drug discovery space with the launch of its Bio Discovery Platform. The new offering aims to make advanced artificial intelligence more accessible to researchers and biopharmaceutical companies, addressing long standing challenges in the drug development pipeline.
Built on AWS cloud infrastructure, the platform combines high performance computing, large scale data storage, and purpose built AI models for biology and chemistry. Researchers can use it to analyse complex genomic, proteomic, and chemical datasets, run virtual screening experiments, predict molecular interactions, and optimise drug candidates more efficiently.
By providing ready to use tools and scalable computing resources, Amazon’s Bio Discovery Platform is expected to shorten the traditionally lengthy and expensive drug discovery timeline. It also promotes collaboration by allowing research teams to securely share data and models across organisations.
This launch reflects Amazon’s growing ambition to apply its cloud and AI expertise to solve critical problems in healthcare and life sciences.
“Our Bio Discovery Platform brings together the power of AWS, advanced AI, and vast biological datasets to help researchers accelerate the discovery of new medicines and improve human health.”
By
HB Team
Related News
